HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cerebral white-matter changes suggesting leukodystrophy in ataxia telangiectasia.

Abstract
Ataxia telangiectasia is an autosomal recessive disorder characterized by progressive cerebellar ataxia, recurrent sinopulmonary infections, oculocutaneous telangiectasia, selective immunoglobulin deficiency, and defective cellular immunity. We report a 4-year-old girl with ataxia telangiectasia whose initial magnetic resonance imaging (MRI) scan at 17 months of age showed leukoencephalopathy compatible with a leukodystrophy, a neuroimaging feature of ataxia telangiectasia that has not been described. Ataxia telangiectasia was not suspected until the child developed more typical clinical features. Diffuse white-matter high signal intensity on T2-weighted MRI scans may occur in the early stages of ataxia telangiectasia. This disease should be considered in the differential diagnosis of any child with a history and MRI findings suggestive of one of the leukodystrophies. The nonneurologic manifestations of ataxia telangiectasia may be of help diagnostically in this clinical setting.
AuthorsE O Chung, J B Bodensteiner, P A Noorani, S S Schochet Jr
JournalJournal of child neurology (J Child Neurol) Vol. 9 Issue 1 Pg. 31-5 (Jan 1994) ISSN: 0883-0738 [Print] United States
PMID7512106 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Carcinoembryonic Antigen
  • alpha-Fetoproteins
Topics
  • Ataxia Telangiectasia (diagnosis, genetics, physiopathology)
  • Brain (diagnostic imaging, physiopathology)
  • Carcinoembryonic Antigen (analysis)
  • Child, Preschool
  • Chromosome Aberrations
  • Chromosome Disorders
  • Diagnosis, Differential
  • Female
  • Humans
  • Leukoencephalopathy, Progressive Multifocal (diagnosis, genetics, physiopathology)
  • Magnetic Resonance Imaging
  • Radiography
  • alpha-Fetoproteins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: